144 related articles for article (PubMed ID: 20202054)
1. Prevalence and prognostic value of cutaneous manifestations in patients with myelodysplastic syndrome.
Farah C; Bulai Livideanu C; Jegu J; Paul C; Viraben R; Lamant L; Delavigne K; Adoue D; Laurent G; Beyne Rauzy O
J Eur Acad Dermatol Venereol; 2010 Oct; 24(10):1171-5. PubMed ID: 20202054
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous manifestations in relation to immunologic parameters in a cohort of primary myelodysplastic syndrome patients.
Dalamaga M; Karmaniolas K; Matekovits A; Migdalis I; Papadavid E
J Eur Acad Dermatol Venereol; 2008 May; 22(5):543-8. PubMed ID: 18070024
[TBL] [Abstract][Full Text] [Related]
3. Analyzing transformation of myelodysplastic syndrome to secondary acute myeloid leukemia using a large patient database.
Shukron O; Vainstein V; Kündgen A; Germing U; Agur Z
Am J Hematol; 2012 Sep; 87(9):853-60. PubMed ID: 22674538
[TBL] [Abstract][Full Text] [Related]
4. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
[TBL] [Abstract][Full Text] [Related]
5. Levels of beta 2 microglobulin have a prognostic relevance for patients with myelodysplastic syndrome with regard to survival and the risk of transformation into acute myelogenous leukemia.
Neumann F; Gattermann N; Barthelmes HU; Haas R; Germing U
Leuk Res; 2009 Feb; 33(2):232-6. PubMed ID: 18639338
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of trisomy 8 in primary myelodysplastic syndrome.
Ma Y; Wang X; Xu X; Lin G
Intern Med J; 2010 Oct; 40(10):697-703. PubMed ID: 19811560
[TBL] [Abstract][Full Text] [Related]
7. [Immunologic phenomena as the first sign of myelodysplastic syndrome].
van Rijn RS; Wittebol S; Graafland AD; Kramer MH
Ned Tijdschr Geneeskd; 2001 Aug; 145(32):1529-33. PubMed ID: 11525083
[TBL] [Abstract][Full Text] [Related]
8. Myeloid leukemia cutis in the setting of myelodysplastic syndrome: a crucial dermatological diagnosis.
Patel LM; Maghari A; Schwartz RA; Kapila R; Morgan AJ; Lambert WC
Int J Dermatol; 2012 Apr; 51(4):383-8. PubMed ID: 22435424
[TBL] [Abstract][Full Text] [Related]
9. Leukemic cluster growth in culture is an independent risk factor for acute myeloid leukemia and short survival in patients with myelodysplastic syndrome.
Bernimoulin M; Stern M; Tichelli A; Jotterand M; Gratwohl A; Nissen C
Acta Haematol; 2008; 119(4):226-35. PubMed ID: 18566541
[TBL] [Abstract][Full Text] [Related]
10. Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression.
Göhring G; Giagounidis A; Büsche G; Kreipe HH; Zimmermann M; Hellström-Lindberg E; Aul C; Schlegelberger B
Ann Hematol; 2010 Apr; 89(4):365-74. PubMed ID: 19855965
[TBL] [Abstract][Full Text] [Related]
11. [Myelodysplastic syndrome--a retrospective study of 38 patients].
Schrappe-Bächer M; Steffen HM; Maier M; Bernards P; Hoeffken A; Fätkenheuer G
Med Klin (Munich); 1990 Sep; 85(9):511-6. PubMed ID: 2233608
[TBL] [Abstract][Full Text] [Related]
12. [Study on the transformation from myelodysplastic syndromes into acute leukemias].
Shi J; Shao Z; Liu H; Li K; Song L; Zhang Y; Zheng Y; Chen G; Chu Y; He H; Zhao M; He G; Feng B; Hao Y; Yang T; Yang C
Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):351-4. PubMed ID: 11877096
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of secondary acute myeloid leukemia is affected by the type of the preceding hematologic disorders and the presence of trisomy 8.
Koh Y; Kim I; Bae JY; Song EY; Kim HK; Yoon SS; Lee DS; Park SS; Park MH; Park S; Kim BK
Jpn J Clin Oncol; 2010 Nov; 40(11):1037-45. PubMed ID: 20587614
[TBL] [Abstract][Full Text] [Related]
14. Low C3 levels is associated with neutropenia in a proportion of patients with myelodysplastic syndrome: retrospective analysis.
Kim KJ; Kwok SK; Park YJ; Kim WU; Cho CS
Int J Rheum Dis; 2012 Feb; 15(1):86-94. PubMed ID: 22324951
[TBL] [Abstract][Full Text] [Related]
15. Myelodysplastic syndromes in patients under 50 years old: a single institution experience.
Breccia M; Mengarelli A; Mancini M; Biondo F; Gentilini F; Latagliata R; Mandelli F; Alimena G
Leuk Res; 2005 Jul; 29(7):749-54. PubMed ID: 15927670
[TBL] [Abstract][Full Text] [Related]
16. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
17. [The prognostic value of a modified WPSS based on routine laboratory parameters in patients with myelodysplastic syndromes: a preliminary result].
Li L; Nie L; Yu MH; Yu Y; Liu L; Qin TJ; Xu ZF; Zhang Y; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2009 May; 30(5):313-7. PubMed ID: 19799126
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow transplantation for myelodysplastic syndrome and secondary leukemia: outcome of 86 patients.
Sutton L; Leblond V; Le Maignan C; Jouet JP; Kuentz M; Gluckman E; Blaise D; Marit G; Attal M; Troussard X
Bone Marrow Transplant; 1991; 7 Suppl 2():39. PubMed ID: 1878712
[No Abstract] [Full Text] [Related]
19. [Prognostic potential of morphological and cytogenetic indices in patients with myelodysplastic syndrome].
Gritsaev SV; Martynkevich IS; Abdulkadyrov KM; Tiranova SA; Kakaĭ MP; Martynenko LS; Dziavgo LA
Ter Arkh; 2005; 77(7):22-7. PubMed ID: 16116904
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the prognostic relevance of L-selectin and ICAM1 expression in myelodysplastic syndromes.
Buccisano F; Maurillo L; Tamburini A; Del Poeta G; Del Principe MI; Ammatuna E; Consalvo MI; Campagna S; Ottaviani L; Sarlo C; Renzi D; Faccia S; Fraboni D; Lo Coco F; Amadori S; Venditti A
Eur J Haematol; 2008 Feb; 80(2):107-14. PubMed ID: 18028430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
